A new report from the ABPI, UK Pharmaceutical Investment Competitiveness Report 2026, concludes that the UK has reversed a long-term decline in pharmaceutical investment. Since September 2025, £2 billion of new investment has been committed to the country, spanning AI-enabled drug discovery through to large-scale manufacturing.
PharmaMedic helps generic manufacturers navigate a growing but challenging market. Click to learn more
At PharmaMedic Consultancy, we offer our specialised services to support healthcare communication agencies in navigating the complexities and challenges that come with delivering compliant and impactful messages in our ever-evolving industry.
We are thrilled to announce a significant milestone in our journey—15 years of dedicated service in the pharmaceutical consulting industry! Thank you to our clients and colleagues for being part of our journey. Here’s to many more years of shared success! Find out more on our service offering.
PharmaMedic's Managing Director, Dr Malcolm Barratt-Johnson joined the National Careers Health Forum on Saturday 11th October, hosted by Developing Your Portfolio at Excel London.
PharmaMedic a UK based medical and biotech consultancy firm, is currently seeking a highly proficient Admin and Marketing Assistant to provide support to our Senior Team and assist with the smooth running of day-to-day operations at our Hertford office.
An independent review by Professor Cathie Sudlow, Uniting the UK’s Health Data: A Huge Opportunity for Society, highlights the urgent need to tackle inefficiencies in the UK’s health data systems. Published on 8 November 2024, the review outlines how outdated processes are preventing the safe and secure use of health data to improve care, drive research, and benefit society.
As 2024 draws to a close, the question on everyone’s mind is — What’s next for medical affairs in 2025? With the healthcare landscape changing at an unprecedented pace, staying ahead means understanding the trends that will define the year ahead. From digital transformation to patient-centric strategies, these shifts are already reshaping the way medical affairs teams operate. Here’s what you need to know to stay prepared and relevant.
A new report from The King’s Fund, NHS and Life Sciences Industry Partnerships: Collaborating to Improve Care, shows how working together can help the NHS improve care. The NHS is under pressure, and joining forces with the life sciences sector could bring in new ideas, tools, and support.
Healthcare today is more complex than ever. Physicians face a torrent of clinical data, treatment guidelines, and disease-specific updates while managing tight schedules. For pharmaceutical companies, this creates a pressing challenge — how to support healthcare providers (HCPs) in delivering better outcomes without overloading them. Medical affairs teams, with their unique blend of science and clinical insight, are ideally placed to meet this need.
